Search

Demao Yang

from Mountain View, CA
Age ~64
Get Report
Also known as:
Demao Bu
Phone and address:
1921 Rock St, Mountain View, CA 94043
(650) 903-0572
Related to:
Chia H Liuchia, 54Fang Yang, 67Chia H Lin, 55Julia Cheng, 38Yun Bu
Connected to:
Abby Yang, 32Addison Yang, 43Aileen C Yang, 51Alexandria L Yang, 33Allerina Yang, 33Alyssa J Yang, 36Amee Yang, 31Amy Yang, 57Andrew Yang, 34Anna Yang, 40

Demao Yang Phones & Addresses

  • 1921 Rock St, Mountain View, CA 94043 (650) 903-0572
  • 1921 Rock St APT 16, Mountain View, CA 94043
  • Palo Alto, CA
  • Syracuse, NY

Work

Company: Guangzhou kanghong therapeutics Jun 2014 Position: Founder and chief executive officer

Education

Degree: Doctorates, Doctor of Philosophy Specialities: Philosophy, Immunology

Skills

Biotechnology • Vaccines • Medical Devices • Pharmaceutical Industry • Molecular Biology • Cell Culture • R&D • Research and Development • Clinical Trials • Sales • Collaboration • Start Ups • Research • Lifesciences • Cell Biology • Biochemistry • Neuroscience • Genomics • Science

Languages

English

Interests

Badminton • Exercise • Soccer • Home Improvement • Reading • Sports • Watching Basketball • History • Home Decoration • Watching Sports • Collecting Coins • Cooking • Electronics • Outdoors • Baseball • Fitness • Music • Camping • Movies • Collecting • Joggin • Diet • Cats • Walking • Travel • Watching Baseball • Investing • Basketball • Stamp Collecting • Self Improvement

Industries

Biotechnology

Resumes

Resumes

Demao Yang Photo 1

Founder And Chief Executive Officer

View page
Location:
1921 Rock St, Mountain View, CA 94043
Industry:
Biotechnology
Work:
Guangzhou Kanghong Therapeutics
Founder and Chief Executive Officer
Zhongxing Yangfan Biotech
Founder and Chief Scientist
Dendreon Jun 1994 - Dec 1999
Scientist
Dnax Research Institute May 1992 - Jun 1994
Postdoctral Fellow
Education:
Beijing Medical College, Beijing, China 1979 - 1984
Bachelors, Bachelor of Medicine, Medicine
Skills:
Biotechnology
Vaccines
Medical Devices
Pharmaceutical Industry
Molecular Biology
Cell Culture
R&D
Research and Development
Clinical Trials
Sales
Collaboration
Start Ups
Research
Lifesciences
Cell Biology
Biochemistry
Neuroscience
Genomics
Science
Interests:
Badminton
Exercise
Soccer
Home Improvement
Reading
Sports
Watching Basketball
History
Home Decoration
Watching Sports
Collecting Coins
Cooking
Electronics
Outdoors
Baseball
Fitness
Music
Camping
Movies
Collecting
Joggin
Diet
Cats
Walking
Travel
Watching Baseball
Investing
Basketball
Stamp Collecting
Self Improvement
Languages:
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
Demao Yang
Principal
B&Y Technologies
Business Services
1921 Rock St, Mountain View, CA 94043
Demao Yang
President
Hema Therapeutics, Inc
1921 Rock St, Mountain View, CA 94043

Publications

Us Patents

Compositions And Treatments For Myelosuppression By Ex Vivo Activated Immune Cells

View page
US Patent:
7332158, Feb 19, 2008
Filed:
Sep 10, 2004
Appl. No.:
10/939168
Inventors:
Demao Yang - Mountain View CA, US
International Classification:
A61K 35/14
C07K 14/475
C07K 14/55
US Classification:
424 937, 514 12, 530351, 530399
Abstract:
The disclosure includes protocols of activating and administering human blood cells to myelosuppressed patients, including patients treated for cancer, e. g. , by chemotherapy or radiation. The protocol may include culturing blood cells in the presence of a cytokine and an ionophore.

Composition And Method For Producing An Immune Response Against Tumor-Related Antigens

View page
US Patent:
7414108, Aug 19, 2008
Filed:
Feb 4, 2004
Appl. No.:
10/772856
Inventors:
Reiner Laus - Bellevue WA, US
Curtis L. Ruegg - Redwood City CA, US
Michael H. Shapero - Redwood City CA, US
Demao Yang - Mountain View CA, US
Assignee:
Dendreon Corporation - Seattle WA
International Classification:
C07K 5/10
US Classification:
530350, 514 2
Abstract:
Disclosed are a novel prostatic acid phosphatase and corresponding coding region derived from mouse. Also disclosed is a method of producing an immune response against an autologous polypeptide tumor antigen by immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation.

Stimulation Of Hematopoiesis By Ex Vivo Activated Immune Cells

View page
US Patent:
7758857, Jul 20, 2010
Filed:
Jul 30, 2008
Appl. No.:
12/220989
Inventors:
Demao Yang - Mountain View CA, US
International Classification:
A61K 35/14
C07K 14/475
C07K 14/55
US Classification:
424 937, 424577, 514 12, 530351, 530399
Abstract:
A protocol of activating and administering human blood cells so that bone marrow histology and/or blood cell counts of patients suffering from a plastic anemia approach normal. The protocol includes culturing the blood cells in the presence of a cytokine and an ionophore. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 C. F. R. 1. 72(b).

Stimulation Of Hematopoiesis By Ex Vivo Activated Immune Cells

View page
US Patent:
20030223968, Dec 4, 2003
Filed:
May 29, 2002
Appl. No.:
10/159148
Inventors:
Demao Yang - Mountain View CA, US
International Classification:
A61K045/00
C12N005/08
A61K038/19
A61K038/20
US Classification:
424/093700, 424/085100, 435/372000, 424/085200
Abstract:
A protocol of activating and administering human blood cells so that bone marrow histology and/or blood cell counts of patients suffering from aplastic anemia approach normal. The protocol includes culturing the blood cells in the presence of a cytokine and an ionophore. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 C.F.R. 1.72().

Stimulation Of Hematopoiesis By Ex Vivo Activated Immune Cells

View page
US Patent:
20050130303, Jun 16, 2005
Filed:
Nov 9, 2004
Appl. No.:
10/984183
Inventors:
Demao Yang - Mountain View CA, US
International Classification:
A61K045/00
C12N005/08
US Classification:
435372000, 424093700, 424085100, 424085200
Abstract:
A protocol of activating and administering human blood cells so that bone marrow histology and/or blood cell counts of patients suffering from a plastic anemia approach normal. The protocol includes culturing the blood cells in the presence of a cytokine and an ionophore. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 C.F.R. 1.72(b).

Compositions And Treatments Using Ex Vivo Activated Cells For Myelosuppressed Patients

View page
US Patent:
20060057121, Mar 16, 2006
Filed:
Sep 10, 2004
Appl. No.:
10/939302
Inventors:
Demao Yang - Mountain View CA, US
International Classification:
A61K 35/14
C12N 5/08
US Classification:
424093700, 435372000
Abstract:
The disclosure includes protocols for activating and administering human blood cells to severely myelosuppressed patients, including patients treated for cancer, e.g., by chemotherapy or radiation. The protocol may include culturing blood cells in the presence of activating agents, for example, a cytokine and an ionophore.

Back Support System For Lower Back Pain

View page
US Patent:
20200121086, Apr 23, 2020
Filed:
Oct 23, 2018
Appl. No.:
16/168431
Inventors:
Demao Yang - Mountain View CA, US
International Classification:
A47C 7/42
Abstract:
A back plate system for recovery of lumbar vertebrae of a human body the system. The system has a plurality of rigid surfaces shaped to place the user's back into a correct posture. A series of the rigid surfaces may be used to gradually bring the user's spine into a correct posture. A first rigid unitary surface has a first concave curve and a first convex curve which reverse direction in a continuous manner. A second rigid unitary surface comprises a second concave curve and a second convex curve which reverse direction in a continuous manner. The height of the second convex curve is greater than the height of the first convex curve. When the series of back plates is used, a user lays on the first rigid unitary surface for a first period of time with the first convex curve under a lumbar region. Then the user lays on the second rigid unitary surface for a second period of time with the second convex curve under the lumbar region.

Cell Therapy For Patients

View page
US Patent:
20190298766, Oct 3, 2019
Filed:
Mar 29, 2018
Appl. No.:
15/940553
Inventors:
Demao Yang - Mountain View CA, US
International Classification:
A61K 35/17
A61P 3/10
A61B 5/145
Abstract:
Materials and methods of treating a patient with type 2 diabetes mellitus, metabolic syndrome, obesity, infertility, high blood pressure, hyperthyroidism, and hypothyroidism, hyperlipidaemia, osteoporosis, osteoarthritis, hypoadrenalism, polycystic ovary syndrome, or Parkinson's disease comprising administering a therapeutically effective amount of ex vivo cultured activated peripheral blood mononuclear cells (PBMCs) to the patient. The ex vivo cultured activated cells are activated and cultured in a presence of a cytokine and may be autologous or allogeneic relative to the patient.
Control profile
Demao Yang from Mountain View, CA, age ~64 Get Report